o,o-diethyl o-3,5,6-trichloro-2-pyridyl phosphate has been researched along with Weight Loss in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buratti, FM; Cometa, MF; Fortuna, S; Lorenzini, P; Meneguz, A; Parisi, L; Testai, E; Volpe, MT | 1 |
| Howard, MD; Karanth, S; Mirajkar, N; Pope, CN | 1 |
2 other study(ies) available for o,o-diethyl o-3,5,6-trichloro-2-pyridyl phosphate and Weight Loss
| Article | Year |
|---|---|
Cholinesterase inhibition and alterations of hepatic metabolism by oral acute and repeated chlorpyrifos administration to mice.
Topics: Acetylcholinesterase; Administration, Oral; Animals; Brain; Chlorpyrifos; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Glutathione; Hydroxylation; Liver; Male; Mice; Microsomes, Liver; Molecular Structure; Pyridones; Testosterone; Weight Loss | 2007 |
Comparative effects of oral chlorpyrifos exposure on cholinesterase activity and muscarinic receptor binding in neonatal and adult rat heart.
Topics: Administration, Oral; Age Factors; Animals; Animals, Newborn; Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide; Chlorpyrifos; Cholinesterases; Female; Heart; Inhibitory Concentration 50; Male; Muscarinic Agonists; Myocardium; Oxotremorine; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Tetraisopropylpyrophosphamide; Weight Gain; Weight Loss | 2007 |